Displaying 493 - 504 items out of 582 results

Press release

Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study

Press release

Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC

Press release

United Kingdom-Based Smoking Cessation Program Reports That 30 Percent of Support in a Lung Cancer Screening Program: The Yorkshire Enhanced Stop Smoking Study (YESS)

Press release

Overall Survival Interim Analysis of a Phase III Study of Atezolizumab vs Best Supportive Care in Resected NSCLC

Press release

International Association for the Study of Lung Cancer Hosts World Conference on Lung Cancer Presidential Symposium Press Briefing on Monday, August 8, 2022

Press release

Sub-Lobar Surgery for Peripheral Non-Small Cell Lung Cancer Non-Inferior to Lobectomy

Press release

NADIM II Trial Provides Further Support for Neoadjuvant Chemoimmunotherapy for Patients with Resectable Non-Small Cell Lung Cancer

Press release

Chinese Researchers Develop Lung Cancer Risk Prediction Nomogram for Female Non-Smokers

Press release

Informed Consent Forms for Lung Cancer Clinical Trials May be a Barrier to Informed Trial Participation

Press release

Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC

Press release

Robotic-Assisted Lobectomy for Early-Stage Lung Cancer Provides Better Patient-Reported Quality of Life Compared to Video-Assisted Lobectomy

Press release

First-Line Pembrolizumab or Placebo Combined With Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term